Contract

Icertis Wins "Contract Management Innovation of The Year" Award from LegalTech Breakthrough

Retrieved on: 
Tuesday, November 15, 2022
Commerce, Technology, Legal technology, 1,000,000, ICI, Discovery, Leadership, Efficiency, Contract, Case management, CEO, Pressure, Practice management software, Science, AI, CLM, Solution, Pharmaceutical industry, Risk management, Cryptocurrency, Documentation, Icertis

BELLEVUE, Wash., Nov. 15, 2022  /PRNewswire/ -- Icertis, the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), today announced it has received the "Contract Management Innovation of the Year" award in the third annual LegalTech Breakthrough Awards program, further strengthening Icertis' market leadership. LegalTech Breakthrough, a leading independent market intelligence organization, conducts the industry's most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the legal technology industry. This year's program attracted more than 1,450 nominations from over 12 countries worldwide.

Key Points: 
  • BELLEVUE, Wash., Nov. 15, 2022 /PRNewswire/ -- Icertis , the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM),today announced it has received the "Contract Management Innovation of the Year" award in the third annual LegalTech Breakthrough Awards program, further strengthening Icertis' market leadership.
  • LegalTech Breakthrough , a leading independent market intelligence organization, conducts the industry's most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the legal technology industry.
  • "The Icertis platform is a breakthrough in contract management and legal technology because its AI-powered solution unlocks the power of contract data to help legal move faster, smarter, and more efficiently."
  • With unmatched technology and category-defining innovation, Icertis pushes the boundaries of what's possible with contract lifecycle management (CLM).

Intermap Reports Third Quarter Results

Retrieved on: 
Tuesday, November 15, 2022
GIS, Growth, TSX, Toronto Stock Exchange, Uncertainty, Government, Collection, SEDAR, Warrant, Asset, Depreciation, IMP, Mission statement, Company, Intelligence, Quality control, Intermap Technologies, Contract, Radar, Solution, Music, Security (finance)

During the third quarter, government sales improved to $1.9 million compared with $0.6 million for the prior year.

Key Points: 
  • During the third quarter, government sales improved to $1.9 million compared with $0.6 million for the prior year.
  • Following a national election in Colombia, including a change in government during the quarter, Intermap experienced booking-to-billing delays as a result of the transition.
  • Commercial sales recognized a 50% increase in subscription-based revenue compared with the third quarter of 2021.
  • Intermap's consolidated financial statements for the quarter ended September 30, 2022, along with management's discussion and analysis for the corresponding period and related management certifications for third quarter financial results, are available on SEDAR at www.sedar.com .

Canada joins with partners to roll out the Global Carbon Pricing Challenge

Retrieved on: 
Tuesday, November 15, 2022
Carbon, Environment, Climate change, Goal, Capital Power Corporation, Partnership, World Bank, Multilateralism, United Kingdom, Cooperative Mechanisms under Article 6 of the Paris Agreement, World, Private sector, COP27, Investment, Contract, Adoption, Pollution, Paris, Challenge, Global Carbon Council, COP26, Government, Renewable energy

Last year, at COP26, Prime Minister Trudeau issued a challenge to triple the global coverage of carbon pricing by 2030.

Key Points: 
  • Last year, at COP26, Prime Minister Trudeau issued a challenge to triple the global coverage of carbon pricing by 2030.
  • The Challenge will also create a forum for dialogue and coordination to make pricing systems more effective and compatible and to support other countries in adopting carbon pricing.
  • At present, about twenty percent of global greenhouse gas emissions are covered by carbon pricing.
  • The Global Carbon Pricing Challenge encourages countries to work toward a collective goal of covering sixty percent of global emissions by 2030.

Packaging Machinery Market worth $56.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 15, 2022
Tetra, Cream, Knowledge, Drink, Automation, SME, Growth, Solution, Efficiency, Luxembourg, R, Health, CMOS, Intelligence, Research, Contract, FFS, Adoption, Aseptic processing, Labelling, GEM, Food, Blister, SIG Combibloc Group, GEA Group, Conveyor system, Bottled water, Fine chemical, Marketing

Form-fill-seal machines (FFS) are automated packaging machines commonly used in the food, beverage, healthcare, pharmaceutical, and consumer products industries for product packaging.

Key Points: 
  • Form-fill-seal machines (FFS) are automated packaging machines commonly used in the food, beverage, healthcare, pharmaceutical, and consumer products industries for product packaging.
  • Rinsing machines, liquid fillers, capping machines, and labelers are the four most important packaging machines on any packaging line for beverage products.
  • The packaging machinery market in North America is expected to grow steadily during the forecast period.
  • MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments.

Vantage launches UK liquidity service for institutional traders

Retrieved on: 
Tuesday, November 15, 2022
Ecosystem, Contract for difference, News, Risk management, Commodity, CFD, FMLS, Vantage, API, Contract, FCA, PAMM, ETF, LSE, Solution, Financial services, Satellite navigation device

LONDON, Nov. 15, 2022 /PRNewswire/ -- International multi-asset trading platform Vantage (or "Vantage Markets") is announcing the launch of Vantage Connect , a liquidity solution for institutions and corporates in the UK.

Key Points: 
  • LONDON, Nov. 15, 2022 /PRNewswire/ -- International multi-asset trading platform Vantage (or "Vantage Markets") is announcing the launch of Vantage Connect , a liquidity solution for institutions and corporates in the UK.
  • Vantage Connect allows these institutional clients to manage volatility effectively and make the most of market opportunities by leveraging Vantage's deep liquidity pool to buy and sell complex assets quickly.
  • Vantage is a global, multi-asset broker offering clients access to a nimble and powerful service for trading CFDs on Forex, Commodities, Indices, Shares and ETFs.
  • With more than 13 years of market experience, Vantage now has over 1,000 employees across more than 30 global offices.

Vantage launches UK liquidity service for institutional traders

Retrieved on: 
Tuesday, November 15, 2022
Ecosystem, Contract for difference, News, Risk management, Commodity, CFD, FMLS, Vantage, Multimedia, API, Contract, FCA, PAMM, ETF, LSE, Solution, Financial services, Satellite navigation device, Online shopping

LONDON, Nov. 15, 2022 /PRNewswire/ -- International multi-asset trading platform Vantage (or "Vantage Markets") is announcing the launch of Vantage Connect , a liquidity solution for institutions and corporates in the UK.

Key Points: 
  • LONDON, Nov. 15, 2022 /PRNewswire/ -- International multi-asset trading platform Vantage (or "Vantage Markets") is announcing the launch of Vantage Connect , a liquidity solution for institutions and corporates in the UK.
  • Vantage Connect allows these institutional clients to manage volatility effectively and make the most of market opportunities by leveraging Vantage's deep liquidity pool to buy and sell complex assets quickly.
  • Vantage is a global, multi-asset broker offering clients access to a nimble and powerful service for trading CFDs on Forex, Commodities, Indices, Shares and ETFs.
  • With more than 13 years of market experience, Vantage now has over 1,000 employees across more than 30 global offices.

Cambodia's Ministry of Environment to Sign Contracts with International Corporations for Over 10 Million Tonnes of Verified Emission Reductions

Retrieved on: 
Tuesday, November 15, 2022
Carbon, Wildlife Conservation Society, Environment, Information systems success model, Bronx Zoo, Climate change, UN, Non-governmental organization, SVP, Government, Corruption, Climate, Zoo, Royal, Partnership, WA, Intergovernmental Panel on Climate Change, Sale, Arbor Day Foundation, Education, Forest, COP27, Vers, VER, Contract, Culture, Ministry, CEO, Indigenous peoples, Wildlife Alliance, Keo Seima Wildlife Sanctuary, Business development, Trading strategy, Science, WCS, Arbor, Agriculture, Renewable energy, Hunting, Everland

SHARM EL SHEIKH, Egypt, Nov. 15, 2022 /PRNewswire/ -- As world leaders gather at COP27 to discuss how to make good on their commitments to end deforestation, the Royal Government of Cambodia's Ministry of Environment agreed today to sign contracts with a select group of international corporate buyers for over 10 million tonnes of Verified Emission Reductions (VERs) from three of Cambodia's pioneering voluntary REDD+ projects, developed by the Wildlife Conservation Society and Wildlife Alliance in partnership with the Royal Government of Cambodia. 

Key Points: 
  • It will not be possible to stabilize the climate below 1.5 degrees of global heating without stopping deforestation by 2030.
  • REDD+ projects address the root causes of deforestation, by enabling governments, local landowners, and forest communities to gain value from conserving their standing forests.
  • Through these sale transactions, the Cambodian Ministry of Environment has secured critical financing to protect some of the most vulnerable forests in Cambodia, and support communities on the frontlines of stopping deforestation.
  • WA's work produces genuine carbon emission reductions and supports local communities whilst protecting the fantastic biodiversity of the Cardamom Rainforest Landscape.

WuXi Vaccines Establishes New Vaccines CDMO Facility in China

Retrieved on: 
Tuesday, November 15, 2022
CDMO, Vaccine, GMP, Contract, DNA, CEO, VLP, CMC, Pharmaceutical industry

SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- WuXi Vaccines, a leading global Contract Development and Manufacturing Organization (CDMO), announced that it has entered into an agreement with Harbour BioMed under which Harbour BioMed's manufacturing facility in Suzhou will be transferred to WuXi Vaccines.

Key Points: 
  • SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- WuXi Vaccines, a leading global Contract Development and Manufacturing Organization (CDMO), announced that it has entered into an agreement with Harbour BioMed under which Harbour BioMed's manufacturing facility in Suzhou will be transferred to WuXi Vaccines.
  • This facility, a new node within WuXi Vaccines global network, will be renovated to provide industry-leading vaccine development and GMP manufacturing services for its global partners.
  • It will also be WuXi Vaccines' first standalone vaccine development and GMP manufacturing site in China.
  • The new facility will expand our capabilities and capacities to better serve our global partners in developing and manufacturing vaccines.

i-80 Gold Ruby Hill Exploration Teach-in Session

Retrieved on: 
Monday, November 14, 2022
Company, Gold, Terminology, Forward-looking statement, Lone Tree, Multimedia, Contract, Industry, View, Risk management

i-80 Gold Corp. is a well-financed, Nevada-focused, mining company with a goal of achieving mid-tier gold producer status through the development of multiple deposits within the Company's advanced-stage property portfolio anticipated to be processed at the centrally located Lone Tree processing facility and autoclave.

Key Points: 
  • i-80 Gold Corp. is a well-financed, Nevada-focused, mining company with a goal of achieving mid-tier gold producer status through the development of multiple deposits within the Company's advanced-stage property portfolio anticipated to be processed at the centrally located Lone Tree processing facility and autoclave.
  • Certain statements in this release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws, including but not limited to, actual production results and costs, outcomes and timing of updated technical studies and future exploration results.
  • These statements reflect the Company's current expectations regarding future events, performance and results and speak only as of the date of this release.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/i-80-gold-ruby-hill-exploration...

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Monday, November 14, 2022
ATM, Security (finance), EUA, University of Pittsburgh Medical Center, Consolidated, Cancer, GNA, Therapy, NCI, Annual report, EST, Blood, Degenerative disease, Infection, IDE, SAN, CRO, COVID, U.S. Securities and Exchange Commission, Board, Government, University, FDA, Contract, Patient, Clinical trial, High-dependency unit, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Securities Act of 1933, EFS, Safety, Emergency Use Authorization, NIH, Head, Director, Drug Quality and Security Act, Food and Drug Administration, ESI, Metastasis, Interest, Neck, Risk, Company, Nasdaq, Insurance, Research, Securities Exchange Act of 1934, UPMC, COVID-19, Internet, Exosome, Review, Food, Disease, Medical device, Vaccine, Pharmaceutical industry, Generic drug, Health insurance, EU

SAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its second quarter ended September 30, 2022 and provided an update on recent developments.

Key Points: 
  • SAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its second quarter ended September 30, 2022 and provided an update on recent developments.
  • Financial Results for the Second Quarter Ended September 30, 2022
    As of September 30, 2022, Aethlon Medical had a cash balance of approximately $19.6 million.
  • The Company will hold a conference call today, Monday, Nov.14, 2022, at 4:30 p.m. EST to review financial results and recent corporate developments.
  • Aethlon Medical is a medical therapeutic company developing the Hemopurifier, a therapeutic blood filtration system indicated for cancer and infectious diseases.